20:36 IST
BSE
Management Change
Dipna Pharmachem Management Change
Dipna Pharmachem appointed two new Independent Directors effective May 11, 2026. Board committees were also reconstituted to enhance governance.
Dipna Pharmachem Ltd
- Share price
- ₹4.04
- Market cap
- ₹10.62 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 4.0×Sector 47.4×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 3Other Announcement 2Management Change 2Price Movement Clarification 1Financial Results 1Board Meeting Date 1
Time
2 announcements with these filters
15:00 IST
BSE
Management Change
Dipna Pharmachem Management Change
Dipna Pharmachem Limited has recommended the appointment of M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26. The Board also approved a postal ballot for member approval via remote e-voting, commencing April 23, 2026.
- Execution
- Financial Year 2025–26